SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-24-005680
Filing Date
2024-04-25
Accepted
2024-04-25 07:02:29
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-25

Document Format Files

Seq Description Document Type Size
1 ARS acrs-20231231xars.pdf ARS 2280366
  Complete submission text file 0001558370-24-005680.txt   3141918
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37581 | Film No.: 24872841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)